|
1
|
Global Report on Diabetes. World Health
Organization. Geneva, Swirzerland: 2016.PubMed/NCBI
|
|
2
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 33(Suppl
1): S62–S69. 2010.PubMed/NCBI
|
|
3
|
Velloso LA, Eizirik DL and Cnop M: Type 2
diabetes mellitus-an autoimmune disease? Nat Rev Endocrinol.
9:750–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Itariu BK and Stulnig TM: Autoimmune
aspects of type 2 diabetes mellitus - A mini-review. Gerontology.
60:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richardson VR, Smith KA and Carter AM:
Adipose tissue inflammation: Feeding the development of type 2
diabetes mellitus. Immunobiology. 218:1497–1504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akash MS, Rehman K and Chen S: Role of
inflammatory mechanisms in pathogenesis of type 2 diabetes
mellitus. J Cell Biochem. 114:525–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sell H, Habich C and Eckel J: Adaptive
immunity in obesity and insulin resistance. Nat Rev Endocrinol.
8:709–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Odegaard JI and Chawla A: Connecting type
1 and type 2 diabetes through innate immunity. Cold Spring Harb
Perspect Med. 2:a0077242012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guzmán-Flores JM and López-Briones S:
Cells of innate and adaptive immunity in type 2 diabetes and
obesity. Gac Med Mex. 148:381–389. 2012.(In Spanish). PubMed/NCBI
|
|
10
|
King GL: The role of inflammatory
cytokines in diabetes and its complications. J Periodontol.
79(Suppl 8): 1527–1534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li YV: Zinc and insulin in pancreatic
beta-cells. Endocrine. 45:175–189. 2014. View Article : Google Scholar
|
|
12
|
Cousins RJ, Liuzzi JP and Lichten LA:
Mammalian zinc transport, trafficking and signals. J Biol Chem.
281:24085–24089. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kambe T, Yamaguchi-Iwai Y, Sasaki R and
Nagao M: Overview of mammalian zinc transporters. Cell Mol Life
Sci. 61:49–68. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chimienti F, Devergnas S, Pattou F, Schuit
F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L,
Grunwald D, Favier A and Seve M: In vivo expression and functional
characterization of the zinc transporter ZnT8 in glucose-induced
insulin secretion. J Cell Sci. 119:4199–4206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chimienti F, Devergnas S, Favier A and
Seve M: Identification and cloning of a beta-cell-specific zinc
transporter, ZnT-8, localized into insulin secretory granules.
Diabetes. 53:2330–2337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lemaire K, Ravier MA, Schraenen A,
Creemers JW, Van de Plas R, Granvik M, Van Lommel L, Waelkens E,
Chimienti F, Rutter GA, et al: Insulin crystallization depends on
zinc transporter ZnT8 expression, but is not required for normal
glucose homeostasis in mice. Proc Natl Acad Sci USA.
106:14872–14877. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pound LD, Sarkar SA, Benninger RK, Wang Y,
Suwanichkul A, Shadoan MK, Printz RL, Oeser JK, Lee CE, Piston DW,
et al: Deletion of the mouse Slc30a8 gene encoding zinc
transporter-8 results in impaired insulin secretion. Biochem J.
421:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wijesekara N, Dai FF, Hardy AB, Giglou PR,
Bhattacharjee A, Koshkin V, Chimienti F, Gaisano HY, Rutter GA and
Wheeler MB: Beta cell-specific Znt8 deletion in mice causes marked
defects in insulin processing, crystallisation and secretion.
Diabetologia. 53:1656–1668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamaki M, Fujitani Y, Uchida T, Hirose T,
Kawamori R and Watada H: Downregulation of ZnT8 expression in
pancreatic β-cells of diabetic mice. Islets. 1:124–128. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jing YL, Sun QM, Bi Y, Shen SM and Zhu DL:
SLC30A8 polymorphism and type 2 diabetes risk: Evidence from 27
study groups. Nutr Metab Cardiovasc Dis. 21:398–405. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Q, Yin JY, Dai XP, Wu J, Chen X,
Deng CS, Yu M, Gong ZC, Zhou HH and Liu ZQ: Association analysis of
SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2
diabetes mellitus and repaglinide response in Chinese patients. Eur
J Clin Pharmacol. 66:1207–1215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Xu Y, Lin Y, Lai X, Yao J, Huang
B, Chen Z, Huang H, Fu X, Lin L, et al: Association study of
genetic variants of 17 diabetes-related genes/loci and
cardiovascular risk and diabetic nephropathy in the Chinese She
population. J Diabetes. 5:136–145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sørgjerd EP, Skorpen F, Kvaløy K,
Midthjell K and Grill V: Prevalence of ZnT8 antibody in relation to
phenotype and SLC30A8 polymorphism in adult autoimmune diabetes:
Results from the HUNT study, Norway. Autoimmunity. 46:74–79. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Skärstrand H, Lernmark A and Vaziri-Sani
F: Antigenicity and epitope specificity of ZnT8 autoantibodies in
type 1 diabetes. Scand J Immunol. 77:21–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vasto S, Mocchegiani E, Malavolta M,
Cuppari I, Listì F, Nuzzo D, Ditta V, Candore G and Caruso C: Zinc
and inflammatory/immune response in aging. Ann N Y Acad Sci.
1100:111–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Egefjord L, Jensen JL, Bang-Berthelsen CH,
Petersen AB, Smidt K, Schmitz O, Karlsen AE, Pociot F, Chimienti F,
Rungby J and Magnusson NE: Zinc transporter gene expression is
regulated by pro-inflammatory cytokines: A potential role for zinc
transporters in beta-cell apoptosis? BMC Endocr Disord. 9:72009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El Muayed M, Billings LK, Raja MR, Zhang
X, Park PJ, Newman MV, Kaufman DB, OHalloran TV and Lowe WL Jr:
Acute cytokine-mediated downregulation of the zinc transporter ZnT8
alters pancreatic beta-cell function. J Endocrinol. 206:159–169.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen ZJ: Ubiquitination in signaling to
and activation of IKK. Immunol Rev. 246:95–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pickart CM and Eddins MJ: Ubiquitin:
Structures, functions, mechanisms. Biochim Biophys Acta.
1695:55–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vereecke L, Beyaert R and van Loo G: The
ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of
immunopathology. Trends Immunol. 30:383–391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hughes LB, Reynolds RJ, Brown EE, Kelley
JM, Thomson B, Conn DL, Jonas BL, Westfall AO, Padilla MA, Callahan
LF, et al: Most common single-nucleotide polymorphisms associated
with rheumatoid arthritis in persons of European ancestry confer
risk of rheumatoid arthritis in African Americans. Arthritis Rheum.
62:3547–3553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tejasvi T, Stuart PE, Chandran V, Voorhees
JJ, Gladman DD, Rahman P, Elder JT and Nair RP: TNFAIP3 gene
polymorphisms are associated with response to TNF blockade in
psoriasis. J Invest Dermatol. 132:593–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fung EY, Smyth DJ, Howson JM, Cooper JD,
Walker NM, Stevens H, Wicker LS and Todd JA: Analysis of 17
autoimmune disease-associated variants in type 1 diabetes
identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun.
10:188–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Graham RR, Cotsapas C, Davies L, Hackett
R, Lessard CJ, Leon JM, Burtt NP, Guiducci C, Parkin M, Gates C, et
al: Genetic variants near TNFAIP3 on 6q23 are associated with
systemic lupus erythematosus. Nat Genet. 40:1059–1061. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Adrianto I, Wen F, Templeton A, Wiley G,
King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, et al:
Association of a functional variant downstream of TNFAIP3 with
systemic lupus erythematosus. Nat Genet. 43:253–258. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eyre S, Hinks A, Bowes J, Flynn E, Martin
P, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, et al:
Overlapping genetic susceptibility variants between three
autoimmune disorders: Rheumatoid arthritis, type 1 diabetes and
coeliac disease. Arthritis Res Ther. 12:R1752010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang H, Ferran C, Attanasio C, Calise F
and Otterbein LE: Induction of protective genes leads to islet
survival and function. J Transplant. 2011:1418982011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grey ST, Longo C, Shukri T, Patel VI,
Csizmadia E, Daniel S, Arvelo MB, Tchipashvili V and Ferran C:
Genetic engineering of a suboptimal islet graft with A20 preserves
beta cell mass and function. J Immunol. 170:6250–6256. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hou CL, Zhang W, Wei Y, Mi JH, Li L, Zhou
ZH, Zeng W and Ying DJ: Zinc finger protein A20 overexpression
inhibits monocyte homing and protects endothelial cells from injury
induced by high glucose. Genet Mol Res. 10:1050–1059. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu LY, Lin B, Zhang ZL and Guo LH: Direct
transfer of A20 gene into pancreas protected mice from
streptozotocin-induced diabetes. Acta Pharmacol Sin. 25:721–726.
2004.PubMed/NCBI
|
|
41
|
Tan BM, Zammit NW, Yam AO, Slattery R,
Walters SN, Malle E and Grey ST: Baculoviral inhibitors of
apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced
nuclear factor κB and c-Jun N-terminal kinase signalling in mouse
pancreatic beta cells. Diabetologia. 56:520–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ortis F, Pirot P, Naamane N, Kreins AY,
Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE,
Chariot A, et al: Induction of nuclear factor-kappaB and its
downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role
in pancreatic beta cells. Diabetologia. 51:1213–1225. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fu Y, Tian W, Pratt EB, Dirling LB, Shyng
SL, Meshul CK and Cohen DM: Down-regulation of ZnT8 expression in
INS-1 rat pancreatic beta cells reduces insulin content and
glucose-inducible insulin secretion. PLoS One. 4:e56792009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang L: Zinc and its transporters,
pancreatic beta-cells, and insulin metabolism. Vitam Horm.
95:365–390. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shembade N, Ma A and Harhaj EW: Inhibition
of NF-kappaB signaling by A20 through disruption of ubiquitin
enzyme complexes. Science. 327:1135–1139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Feve B and Bastard JP: The role of
interleukins in insulin resistance and type 2 diabetes mellitus.
Nat Rev Endocrinol. 5:305–311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reinehr T, Karges B, Meissner T, Wiegand
S, Stoffel-Wagner B, Holl RW and Woelfle J: Inflammatory markers in
obese adolescents with type 2 diabetes and their relationship to
hepatokines and adipokines. J Pediatr. S0022-3476(16): 00277–8.
2016.
|
|
48
|
Liuwantara D, Elliot M, Smith MW, Yam AO,
Walters SN, Marino E, McShea A and Grey ST: Nuclear factor-kappaB
regulates beta-cell death: A critical role for A20 in beta-cell
protection. Diabetes. 55:2491–2501. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Melloul D: Role of NF-kappaB in beta-cell
death. Biochem Soc Trans. 36:334–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen
S and Eizirik DL: Mechanisms of pancreatic beta-cell death in type
1 and type 2 diabetes: Many differences, few similarities.
Diabetes. 54(Suppl 2): S97–S107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Baltimore D: NF-κB is 25. Nat Immunol.
12:683–685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu XH, Wang YP, Wang LX, Chen Z, Liu XY
and Liu LB: Exendin-4 protects murine MIN6 pancreatic β-cells from
interleukin-1β-induced apoptosis via the NF-κB pathway. J
Endocrinol Invest. 36:803–811. 2013.PubMed/NCBI
|
|
53
|
Eldor R, Abel R, Sever D, Sadoun G, Peled
A, Sionov R and Melloul D: Inhibition of nuclear factor-κB
activation in pancreatic β-cells has a protective effect on
allogeneic pancreatic islet graft survival. PLoS One. 8:e569242013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kiechl S, Wittmann J, Giaccari A, Knoflach
M, Willeit P, Bozec A, Moschen AR, Muscogiuri G, Sorice GP, Kireva
T, et al: Blockade of receptor activator of nuclear factor-κB
(RANKL) signaling improves hepatic insulin resistance and prevents
development of diabetes mellitus. Nat Med. 19:358–363. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kim HS, Han MS, Chung KW, Kim S, Kim E,
Kim MJ, Jang E, Lee HA, Youn J, Akira S and Lee MS: Toll-like
receptor 2 senses beta-cell death and contributes to the initiation
of autoimmune diabetes. Immunity. 27:321–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Coornaert B, Carpentier I and Beyaert R:
A20: Central gatekeeper in inflammation and immunity. J Biol Chem.
284:8217–8221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wertz IE, Newton K, Seshasayee D, Kusam S,
Lam C, Zhang J, Popovych N, Helgason E, Schoeffler A, Jeet S, et
al: Phosphorylation and linear ubiquitin direct A20 inhibition of
inflammation. Nature. 528:370–375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhou Q, Wang H, Schwartz DM, Stoffels M,
Park YH, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, et al:
Loss-of-function mutations in TNFAIP3 leading to A20
haploinsufficiency cause an early-onset autoinflammatory disease.
Nat Genet. 48:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cheng L, Zhang D, Jiang Y, Deng W, Wu Q,
Jiang X and Chen B: Decreased A20 mRNA and protein expression in
peripheral blood mononuclear cells in patients with type 2 diabetes
and latent autoimmune diabetes in adults. Diabetes Res Clin Pract.
106:611–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li D, Wang L, Fan Y, Song L, Guo C, Zhu F,
Zhang L and Shi Y: Down-regulation of A20 mRNA expression in
peripheral blood mononuclear cells from patients with systemic
lupus erythematosus. J Clin Immunol. 32:1287–1291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sarkar SA, Kutlu B, Velmurugan K,
Kizaka-Kondoh S, Lee CE, Wong R, Valentine A, Davidson HW, Hutton
JC and Pugazhenthi S: Cytokine-mediated induction of anti-apoptotic
genes that are linked to nuclear factor kappa-B (NF-kappaB)
signalling in human islets and in a mouse beta cell line.
Diabetologia. 52:1092–1101. 2009. View Article : Google Scholar : PubMed/NCBI
|
